Federal Register / Vol. 89, No. 9 / Friday, January 12, 2024 / Notices 2225 

hours per response for lump sum 

payment elections. 

Frequency of Response: One time 

reporting requirement. 

Obligation to Respond: Statutory 

authority for this information collection 

is contained in sections 1, 2, 4(i), 4(j), 

5(c), 201, 302, 303, 304, 307(e), and 

309of the Communications Act of 1934, 

as amended, 47 U.S.C. 151, 152, 154(i), 

154(j), 155(c), 201, 302, 303, 304, 307(e), 

309. 

Total Annual Burden: 109,680 hours. 

Total Annual Cost: $900,000. 

Needs and Uses: Under this 

information collection, the Commission 

will collect information that will be 

used to determine when, how, and at 

what cost existing operations in the 

lower portion of the 3.7–4.2 GHz band 

will be relocated to the upper portion of 

the band. This collection will serve as 

the starting point for planning and 

managing the process of efficiently and 

expeditiously clearing of the lower 

portion of the band, so that this 

spectrum can be auctioned for flexibleuse service licenses. 

The transition relocation process 

began in 2020. Initial Transition Plans 

were filed on June 19, 2020 with final 

Transition Plans due August 14, 2020. 

Throughout the relocation process, the 

Wireless Telecommunications Bureau 

(Bureau) opened limited windows to 

amend their Transition Plans on several 

occasions. In addition to submitting and 

modifying Transition Plans during these 

periods, eligible space station operators 

were required to file quarterly status 

reports with the Commission beginning 

on December 31, 2020 to demonstrate 

their efforts to ensure a timely 

transition. 

The 3.7 GHz band auction, Auction 

107, took place from December 8, 2020 

to February 17, 2021, and, on February 

24, 2021, the Commission announced 

the winning bidders of the C-band 

auction for all 5,684 licenses. In the 

same year, the Bureau directed eligible 

space station operators to submit 

updates for their final Transition Plans 

during limited windows opened for 

operators to provide these updates. 

Later that year, on August 4, 2021, the 

Bureau issued a Public Notice 

implementing filing procedures for 

Phase I Certifications. Originally, Phase 

I’s deadline was set for December 5, 

2021, but the deadline was met eleven 

days earlier than anticipated. On 

November 24, 2021, the Commission 

validated the certification of Phase I. 

The C-band transition continued into 

2023. On May 15, 2023, the Bureau 

announced procedures for filing C-band 

Phase II Certifications of Accelerated 

Relocation and implementation of the 

Commission’s incremental reduction 

plan for Phase II Accelerated Relocation 

Payments as part of the ongoing 

transition. The C-Band Relocation 

Payment Clearinghouse (RPC) is 

responsible for disbursing the 

Accelerated Relocation Payments within 

a certain time period. 

On June 1, 2023, all eligible space 

station operators were permitted to 

submit their Phase II certifications. Also 

on June 1, 2023, the Bureau opened a 

limited, final window for eligible space 

station operators to file modified 

Transition Plans to accurately account 

for any updates since September 30, 

2021. 

Phase II’s deadline to complete the 

transition of space station operations to 

the upper 200 megahertz of the band 

was originally set for December 5, 2023. 

Instead, on August 10, 2023, the last of 

the Phase II Certifications was deemed 

granted. Even though Phases I and II of 

the satellite transition are complete, the 

Commission continues to work through 

the C-band relocation process. On 

October 13, 2023, the Bureau released a 

Public Notice seeking comment on 

proposed deadlines for claimants to 

submit reimbursement claims. The 

Public Notice stated that the RPC’s 

operations are currently scheduled to 

conclude on June 30, 2025, which is 

still more than a year and a half away. 

The relocation of the fixed service 

licensees is also ongoing. 

On December 5, 2023, the 

Commission issued a Public Notice 

adopting two final reimbursement 

claims submission deadlines for eligible 

incumbents and other eligible 

stakeholders to submit any outstanding 

transition-related claims to the RPC for 

processing as part of this ongoing 

transition. The two deadlines are: (1) 

February 5, 2024 as the submission 

deadline to the RPC for all 

reimbursement claims for costs incurred 

and paid by claimants as of December 

31, 2023, and (2) July 1, 2024 as the 

submission deadline to the RPC for all 

reimbursement claims for costs incurred 

and paid by claimants after December 

31, 2023. In the Public Notice, the 

Commission stated that these adopted 

dates are important because they will 

aid in facilitating a timely conclusion of 

the C-band reimbursement program. 

Furthermore, the Commission 

highlighted the fact that all lump sum 

electees and many other eligible 

claimants and eligible stakeholders have 

had ample time within which to submit 

their claims to the RPC. 

It is important to continue to collect 

information because it is crucial to 

ensure that managing this process is 

efficiently and quickly done, and that 

transition is still underway. Because 

this process remains ongoing, this 

information collection should be 

renewed to ensure that a complete set of 

information is maintained. If this 

collection were to expire now, 

stakeholders would be missing ongoing 

information about the transition 

process. Renewing this collection will 

provide stakeholders with complete 

information instead of an information 

collection that ends before the entire 

transition process is officially 

accomplished in 2025. 

Federal Communications Commission. 

Marlene Dortch, 

Secretary, Office of the Secretary. 

[FR Doc. 2024–00495 Filed 1–11–24; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL HOUSING FINANCE 

AGENCY 

[No. 2024–N–1] 

Notice of Annual Adjustment of the 

Cap on Average Total Assets That 

Defines Community Financial 

Institutions 

AGENCY: Federal Housing Finance 

Agency. 

ACTION: Notice. 

SUMMARY: The Federal Housing Finance 

Agency (FHFA) has adjusted the cap on 

average total assets that is used in 

determining whether a Federal Home 

Loan Bank (Bank) member qualifies as 

a ‘‘community financial institution’’ 

(CFI) to $1,461,000,000, based on the 

annual percentage increase in the 

Consumer Price Index for all urban 

consumers (CPI–U), as published by the 

Department of Labor (DOL). These 

changes are effective as of January 1, 

2024. 

FOR FURTHER INFORMATION CONTACT: 

Janna Bruce, Division of Federal Home 

Loan Bank Regulation, (202) 649–3202, 

Janna.Bruce@fhfa.gov; or Carly 

Malamud, Counsel, Office of General 

Counsel, (202) 649–3098, 

Carly.Malamud@fhfa.gov, (these are not 

toll-free numbers), Federal Housing 

Finance Agency, Constitution Center, 

400 Seventh Street SW, Washington, DC 

20219. For TTY/TRS users with hearing 

and speech disabilities, dial 711 and ask 

to be connected to any of the contact 

numbers above. 

SUPPLEMENTARY INFORMATION: 

I. Statutory and Regulatory Background 

The Federal Home Loan Bank Act 

(Bank Act) confers upon insured 

depository institutions that meet the 


khammond on DSKJM1Z7X2PROD with NOTICES
2226 Federal Register / Vol. 89, No. 9 / Friday, January 12, 2024 / Notices 

1See 12 U.S.C. 1424(a), 1430(a). 

2See 12 U.S.C. 1422(10)(A); 12 CFR 1263.1. 

3See 12 U.S.C. 1422(10)(B); 12 CFR 1263.1 

(defining the term ‘‘CFI asset cap’’). 

4See 87 FR 80184 (Dec. 29, 2022). 

statutory definition of a CFI certain 

advantages over non-CFI insured 

depository institutions in qualifying for 

Bank membership, and in the purposes 

for which they may receive long-term 

advances and the collateral they may 

pledge to secure advances.1 Section 

2(10)(A) of the Bank Act and § 1263.1 of 

FHFA’s regulations define a CFI as any 

Bank member the deposits of which are 

insured by the Federal Deposit 

Insurance Corporation and that has 

average total assets below the statutory 

cap.2 The Bank Act was amended in 

2008 to set the statutory cap at $1 

billion and to require FHFA to adjust 

the cap annually to reflect the 

percentage increase in the CPI–U, as 

published by the DOL.3 For 2023, FHFA 

set the CFI asset cap at $1,417,000,000, 

which reflected a 7.1 percent increase 

over 2022, based upon the increase in 

the CPI–U between 2021 and 2022.4

II. The CFI Asset Cap for 2024 

As of January 1, 2024, FHFA will 

increase the CFI asset cap to 

$1,461,000,000, which reflects a 3.1 

percent increase in the unadjusted CPI– 

U from November 2022 to November 

2023. Consistent with the practice of 

other Federal agencies required to 

calculate and make annual adjustments 

based on CPI–U changes, FHFA bases 

the annual adjustment to the CFI asset 

cap on the percentage increase in the 

CPI–U from November of the year prior 

to the preceding calendar year to 

November of the preceding calendar 

year, because the November figures 

represent the most recent available data 

as of January 1st of the current calendar 

year. The new CFI asset cap was 

obtained by applying the percentage 

increase in the CPI–U to the unrounded 

amount for the preceding year and 

rounding to the nearest million, as has 

been FHFA’s practice for all previous 

adjustments. 

In calculating the CFI asset cap, FHFA 

uses CPI–U data that have not been 

seasonally adjusted (i.e., the data have 

not been adjusted to remove the 

estimated effect of price changes that 

normally occur at the same time and in 

about the same magnitude every year). 

The DOL encourages use of unadjusted 

CPI–U data in applying ‘‘escalation’’ 

provisions such as that governing the 

CFI asset cap, because the factors that 

are used to seasonally adjust the data 

are amended annually, and seasonally 

adjusted data that are published earlier 

are subject to revision for up to five 

years following their original release. 

Unadjusted data are not routinely 

subject to revision, and previously 

published unadjusted data are only 

corrected when significant calculation 

errors are discovered. 

Joshua R. Stallings, 

Deputy Director, Division of Federal Home 

Loan Bank Regulation, Federal Housing 

Finance Agency. 

[FR Doc. 2024–00491 Filed 1–11–24; 8:45 am] 

BILLING CODE 8070–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on The Effect of Dietary 

Digestible Carbohydrate Intake on Risk 

of Cardiovascular Disease 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for supplemental 

evidence and data submission. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

The Effect of Dietary Digestible 

Carbohydrate Intake on Risk of 

Cardiovascular Disease, which is 

currently being conducted by the 

AHRQ’s Evidence-based Practice 

Centers (EPC) Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. 

DATES: Submission Deadline on or 

before February 12, 2024. 

ADDRESSES:

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers 

Lane, Mail Stop 06E77D, Rockville, 

MD 20857 

FOR FURTHER INFORMATION CONTACT: 

Kelly Carper, Telephone: 301–427–1656 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for The Effect of Dietary 

Digestible Carbohydrate Intake on Risk 

of Cardiovascular Disease. AHRQ is 

conducting this review pursuant to 

Section 902 of the Public Health Service 

Act, 42 U.S.C. 299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on The Effect of Dietary 

Digestible Carbohydrate Intake on Risk 

of Cardiovascular Disease. 

The entire research protocol is 

available online at: https://effective

healthcare.ahrq.gov/products/riskcardiovascular-disease. 

This is to notify the public that the 

EPC Program would find the following 

information on The Effect of Dietary 

Digestible Carbohydrate Intake on Risk 

of Cardiovascular Disease helpful: 

D A list of completed studies that 

your organization has sponsored for this 

topic. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements, if relevant: study number, 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, primary and secondary 

outcomes, baseline characteristics, 

number of patients screened/eligible/ 

enrolled/lost to follow-up/withdrawn/ 

analyzed, effectiveness/efficacy, and 

safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

topic. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including, if relevant, a study 

number, the study period, design, 

methodology, indication and diagnosis, 

proper use instructions, inclusion and 

exclusion criteria, and primary and 

secondary outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this topic and an index 

outlining the relevant information in 

each submitted file. 


khammond on DSKJM1Z7X2PROD with NOTICES